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Review question
- What study designs are used to investigate the physical and social aspects of the community pharmacy
environment?
- What are pharmacy patients' and staffs' experiences of the physical and social aspects of the community
pharmacy environment when accessing or delivering pharmacy health services?
- What barriers and enablers, relating to the community pharmacy environment, do pharmacy patients and
staff experience; and possible health, social or professional implications of this? 
 
Searches
Eighteen databases will be searched from their start to 18th August 2018 (host sites given in parentheses): 
MEDLINE (Ovid), Embase (Ovid), Cumulative Index to Nursing and Allied Health Literature (CINAHL),
PsycINFO, Social Science Citation Index (Web of Science), Web of Science Core Collection, Scopus,
ScienceDirect, Journal Storage (JSTOR), International Construction Database (ICONDA), Avery Index to
Architectural Periodicals, Applied Social Sciences Index and Abstracts (ASSIA), International Bibliography of
the Social Sciences, Sociological Abstracts, Social Services Abstracts, Cochrane Central Register of
Controlled Trials (CENTRAL), Health Technology Assessment Database and Social Care Online (SCIE).
Experts in the fields of pharmacy practice, architecture, design and other related disciplines, as identified in
the literature, will also be consulted. The bibliographies and reference lists of all included articles will be
searched for further relevant publications.
Searches will be limited to peer-reviewed publications. Only English language publications will be reviewed.
Publications will not be excluded based on publication date. If studies identified do not have sufficient data,
attempts will be made to contact authors to obtain any relevant information that is missing.
 
Search strategy
https://www.crd.york.ac.uk/PROSPEROFILES/75031_STRATEGY_20180527.pdf
 
Types of study to be included
Only publications which report empirical data of any study design will be included, but not reviews or reports. 
 
Condition or domain being studied
Any reported health, social or professional outcomes which capture pharmacy patients' and staffs'
experience of the physical and social aspects of the community pharmacy environment when accessing or
delivering pharmacy health services. 
 
Participants/population
- Pharmacy patients – all ages in any country who are accessing community pharmacy health services.
- All members of the pharmacy health team. These include: pharmacists, pre-registration pharmacists,
dispensing staff, accredited checking technicians and medicines counter staff.
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Intervention(s), exposure(s)
A community pharmacy is defined as accessible to all, and not based in a hospital, clinic or online.
Pharmacies maybe located within rural and/or and urban areas, with differing levels of deprivation.
Pharmacies may also form part of a multiple chain or be independently owned.
 
Comparator(s)/control
We will include studies with and without controls. 
 
Context
Included studies will report how spaces within the community pharmacy environment is experienced by
pharmacy patients and staff when accessing or delivering pharmacy health services. These spaces can
include the pharmacy health counter, dispensary area, consultation room or the pharmacy retail area. The
studies may originate from any community pharmacy setting worldwide, encompassing: high; middle; and
low income countries.
 
Main outcome(s)
- To identify pharmacy  patients' and staffs' experience of the physical and social aspects of the community
pharmacy environment when accessing or delivering pharmacy health services.  
- To identify environmental factors which may influence pharmacy staffs' and patients' engagement with
pharmacy health services; and possible health, social or professional implications of this. 
Timing and effect measures
 
Additional outcome(s)
- To identify study designs used to understand pharmacy patients' and staffs' experience of the physical and
social aspects of the community pharmacy environment when accessing or delivering pharmacy health
services.
Timing and effect measures
 
Data extraction (selection and coding)
- The initial screening of titles, abstracts and full text will be conducted by RD; with a 20% random sample, at
each stage, independently screened by JS and CV.
- Data extraction from full texts of included studies will be conducted by RD, and again 20% of random
sample will be checked independently by JS and CV.
- Data extraction will be conducted using established data extraction forms which will be adapted and refined
for the purposes of this review. 
- Any discrepancies will be resolved through discussion between the RD, JS and CV, and if consensus is not
reached then other study authors (GR and RG) will be consulted to review as a team. 
 
Risk of bias (quality) assessment
The quality of each selected study will be assessed by RD, JS and CV (100% of selected studies),
independently and in parallel to each other. We will use the Integrated quality Criteria for the Review Of
Multiple Study designs (ICROMS), choosing the most appropriate study design criteria for each study. Any
potential risk of bias will be reviewed through discussion between RD, JS and CV, and if consensus cannot
be reached then other study authors (GR and RG) will be consulted to review as a team.
 
Strategy for data synthesis
As we will include studies which report empirical data, from both qualitative and quantitative research
designs, we will therefore use quantitative or narrative synthesis; depending on the types of studies included
for the review.  
 
Analysis of subgroups or subsets
We will conduct sub-group or sub-set analysis if such data is identified. 
 
Contact details for further information
Dr Ranjita Dhital
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 Stage Started Completed
Preliminary searches Yes No
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